Jia-Wang Wang1, Yan Li1, Wan Nie1, Zhe Chang1, Zi-An Yu1, Yi-Fan Zhao1, Xi Lu2, Yao Fu3. 1. Hefei National Laboratory for Physical Sciences at the Microscale, CAS Key Laboratory of Urban Pollutant Conversion, Anhui Province Key Laboratory of Biomass Clean Energy, iChEM, University of Science and Technology of China, Hefei, 230026, China. 2. Hefei National Laboratory for Physical Sciences at the Microscale, CAS Key Laboratory of Urban Pollutant Conversion, Anhui Province Key Laboratory of Biomass Clean Energy, iChEM, University of Science and Technology of China, Hefei, 230026, China. luxi@mail.ustc.edu.cn. 3. Hefei National Laboratory for Physical Sciences at the Microscale, CAS Key Laboratory of Urban Pollutant Conversion, Anhui Province Key Laboratory of Biomass Clean Energy, iChEM, University of Science and Technology of China, Hefei, 230026, China. fuyao@ustc.edu.cn.
Abstract
To increase the reliability and success rate of drug discovery, efforts have been made to increase the C(sp3) fraction and avoid flat molecules. sp3-Rich enantiopure amines are most frequently encountered as chiral auxiliaries, synthetic intermediates for pharmaceutical agents and bioactive natural products. Streamlined construction of chiral aliphatic amines has long been regarded as a paramount challenge. Mainstream approaches, including hydrogenation of enamines and imines, C-H amination, and alkylation of imines, were applied for the synthesis of chiral amines with circumscribed skeleton structures; typically, the chiral carbon centre was adjacent to an auxiliary aryl or ester group. Herein, we report a mild and general nickel-catalysed asymmetric reductive hydroalkylation to effectively convert enamides and enecarbamates into drug-like α-branched chiral amines and derivatives. This reaction involves the regio- and stereoselective hydrometallation of an enamide or enecarbamate to generate a catalytic amount of enantioenriched alkylnickel intermediate, followed by C-C bond formation via alkyl electrophiles.
To increase the reliability and success rate of drug discovery, efforts have been made to increase the C(sp3) frn class="Chemical">action and avoid flat molecules. sp3-Rich enantiopure aminesare most frequently encountered as chiral auxiliaries, synthetic intermediates for pharmaceutical agents and bioactive natural products. Streamlined construction of chiral aliphaticamines has long been regarded as a paramount challenge. Mainstream approaches, including hydrogenation of enamines and imines, C-H amination, and alkylation of imines, were applied for the synthesis of chiral amines with circumscribed skeleton structures; typically, the chiral carbon centre was adjacent to an auxiliary aryl or ester group. Herein, we report a mild and general nickel-catalysed asymmetric reductive hydroalkylation to effectively convert enamides and enecarbamates into drug-like α-branched chiral amines and derivatives. This reaction involves the regio- and stereoselective hydrometallation of an enamide or enecarbamate to generate a catalytic amount of enantioenriched alkylnickel intermediate, followed by C-C bond formation via alkyl electrophiles.
Authors: Markus Lindqvist; Katja Borre; Kirill Axenov; Bianka Kótai; Martin Nieger; Markku Leskelä; Imre Pápai; Timo Repo Journal: J Am Chem Soc Date: 2015-02-04 Impact factor: 15.419
Authors: Andrew J Musacchio; Brendan C Lainhart; Xin Zhang; Saeed G Naguib; Trevor C Sherwood; Robert R Knowles Journal: Science Date: 2017-02-17 Impact factor: 47.728
Authors: Jesus Rodrigalvarez; Manuel Nappi; Hiroki Azuma; Nils J Flodén; Matthew E Burns; Matthew J Gaunt Journal: Nat Chem Date: 2019-12-20 Impact factor: 24.427